Riskpilot← Back to searchSign inGet full accessSpectraCure AB (publ)
ABActiveOrg 5566421011Gasverksgatan 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 200310-19 employees
Revenue 2024
SEK 0
EBITDA margin
—
-9% vs 2023
Equity ratio
92.3%
Financial strength
Net profit 2024
SEK -23M
-13% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -23,1M | -9% |
| Net profit | SEK -23M | -13% |
| Total assets | SEK 116,4M | -16% |
| Equity | SEK 107,3M | -18% |
| Employees | — | — |
Legal name
SpectraCure AB (publ)
Org number
5566421011
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20 mars 2003
Share capital
SEK 9 713 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet ska vara att bedriva utveckling inommedicinska/medicinsktekniska produkter samt härmed förenlig verksamhet.
Address
Gasverksgatan 1
Phone
+46462863770
Email
jsw@spectracure.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −15 050 | −22 785 | −25 352 | −21 217 | −23 050 |
| Depreciation & amort. | −402 | −506 | −559 | −553 | −435 |
| EBIT | −15 452 | −23 291 | −25 911 | −21 770 | −23 485 |
| Net financials | 154 | 208 | 525 | 1 409 | 507 |
| Profit before tax | −15 298 | −23 083 | −25 386 | −20 361 | −22 978 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −15 298 | −23 083 | −25 386 | −20 361 | −22 978 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 205 311 | 186 013 | 160 109 | 138 585 | 116 351 |
| Equity | 197 353 | 176 075 | 150 688 | 130 327 | 107 349 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 958 | 9 938 | 9 421 | 8 258 | 9 002 |
| Total debt | 7 958 | 9 938 | 9 421 | 8 258 | 9 002 |
EBITDA margin
-2305000000.0%
This company
15.8%
Market median
-14588607695% vs market
20202024
Equity ratio
92.3%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
-21.4%
This company
18.4%
Market median
-216% vs market
20202024
Net profit margin
-2297800000.0%
This company
8.1%
Market median
-28367901335% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JE Chief Auditor | Chief Auditor | 2021 |
JP Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Former (5) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SpectraCure AB (publ) 
SPCIN ABBoard members of SpectraCure AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Ebbe Nihlberg | Chief Auditor | 0 companies |
| Johan Olof Folkunger | Chief Executive Officer | 0 companies |
| Johannes Per Swartling | Chief Executive Officer | 0 companies |
| Tomas Kramar | Board of Directors | 0 companies |
| Katarina Svanberg | Board of Directors | 0 companies |
| Hans Erik Daniel Otto Bornefalk | Board of Directors | 0 companies |
| Per Stefan Andersson Engels | Board of Directors | 0 companies |
| Per Ola Jesper Freij | Board of Directors | 0 companies |
| Masoud Khayyami | Board of Directors | 0 companies |
| Bert Patrik Ringblom | Board of Directors | 0 companies |
| Gustav Ingemar Kihlström | Chairman | 0 companies |
| Homer Hung Pien | Board of Directors | 0 companies |
| Jörgen Wennberg | Chairman | 0 companies |
| Sune Roland Svanberg | Board of Directors | 0 companies |